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Antibiotics and antimycotics generally work well
against bacterial or fungal infections, but the progres-
sive increase in bacterial and fungal resistance has sti-
mulated the search for new therapeutic approaches.
Many researchers have concentrated on investigating
the essential oils of plants because, first empirically
but now scientifically, it has been found that they
interfere with micro-organisms in various ways (1-5).
Over the last 20 years, more than 600 studies have
investigated and confirmed the antimicrobial effects
of essential oils on various different bacteria and
fungi using modern pharmacological techniques (1).
The essential oils of plants are very complex mixtures
of various components (therpenes, aldehydes,
SUMMARY: Timolo: antibatterico, antifungo e antiossidante attivo.
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Adhesion is the essential prerequisite for the pathogenesis of bacterial and
fungal infections because the micro-organisms must adhere to host mucosal cells
in order to multiply and create colonies before specific symptoms allow the dis-
ease to be detected. This is particularly true in the case of female urogenital
infections such as urinary tract infections, bacterial vaginosis and vaginitis. It
has been reported that tymol, a component of thyme essential oil, has interest-
ing antimicrobial effects on various micro-organisms and can interact with
adhesiveness, a major determinant of bacterial and fungal virulence. It signifi-
cantly reduces Escherichia coli adhesion to human vaginal epithelial cells
(VECs) at concentrations ranging from 1/2 MIC to 1/32 MIC, and that
of Staphylococcus aureus at concentrations ranging from 1/2 MIC to
1/16 MIC. Candida albicans is particularly capable of adhering to VECs
endothelial cells, soluble factors and extracellular matrix, but its incubation
with thymol reduces its adhesion to VECs with a significant linear relation-
ship from 1/2 MIC to 1/8 MIC.
Phenolic compounds such as thymol also play an important role as a
result of their anti-oxidant activity. During respiratory bursts and the killing
of micro-organisms, neutrophils generate reactive oxygen species whose release
can induce oxidative stress and tissue injury. The use of luminol amplified
chemiluminescence has shown that thymol incubated with human neutrophils
significantly reduces oxidative bursts down to 2.73 µg/ml, a very low concen-
tration.
Together with the other findings concerning bacterial and fungal adhe-
sion, the antioxidant activity of thymol is useful for the strategy of protecting
against vaginosis or vaginitis using new compounds other than antibiotics or
antimycotics, because the presence in only one molecule of antibacterial, anti-
fungal and anti-oxidant activities may have sinergistic effects.
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L’adesione è un prerequisito essenziale per la patogenesi delle infezioni
batteriche e fungine perchè i micro-organismi devono aderire alle cellule della
mucosa ospite per potersi moltiplicare e creare colonie prima che compaiano i
sintomi specifici che indichino la presenza della malattia. Questo è particolar-
mente vero nel caso di infezioni urogenitali femminili quali infezioni  del tratto
urinario, vaginosi batterica e vaginiti. È stato riportato che il timolo, un com-
ponente dell’ olio essenziale di timo, possiede interessanti effetti antimicrobici su
vari micro-organismi e può interagire con l’adesività, un importante determi-
nante di virulenza batterica e fungina. Il timolo riduce significativamente l’ade-
sione di Escherichia coli alle cellule epiteliali vaginali umane (VECs) a con-
centrazioni tra 1/2 MIC e 1/32 MIC, e quella di Staphylococcus aureus a
concentrazioni tra 1/2 MIC e 1/16 MIC. La Candida albicans è partico-
larmente abile nell’aderire a cellule VECs, a fattori solubili ed alla matrice
extracellulare, ma la sua incubazione con il timolo riduce la sua adesione a
VECs con una correlazione lineare significativa da 1/2 MIC a 1/8 MIC.
Composti fenolici quali il timolo giocano un ruolo importante anche sulla
base della loro attività anti-ossidante. Durante il “respiratory burst” e il
“killing” di micro-organismi, i neutrofili generano varie specie reattive
dell’ossigeno la cui liberazione può indurre stress ossidativo e lesioni tissutali.
L’impiego della chemiluminescenza amplificata con luminol ha mostrato che
il timolo incubato con neutrofili umani riduce significativamente il burst ossi-
dativo già a 2.73 µg/ml, una concentrazione molto bassa.
Unitamente alle altre evidenze sull’adesione di batteri e funghi, l’attività
antiossidante del timolo appare utile nella strategia di protezione dalle vagino-
si o vaginiti usando nuovi composti diversi dagli antibiotici o antimicotici, in
quanto la presenza in una sola molecola come quella del timolo di attività
antibatterica, antifungina e anti-ossidante può avere effetti sinergici.
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alcohols, acyclic esters, etc.) with different chemoty-
pes, and a number of investigations have found that
those of thyme are highly antimicrobial (6-10) mainly
because of their high phenol content (7, 11, 12).
Thymol, one of the major components of thyme
oil with a phenolic structure, has useful antimicrobial
activity against various micro-organisms (1, 13, 14),
but its ability to interact with such an important
determinant of virulence as bacterial and fungal adhe-
siveness has not yet been investigated. The adhesion
of bacteria and fungi to human mucosae is important
because it offers many advantages for the survival of
the enormous number of micro-organisms present in
the environment. It has now been clinically confir-
med that, if there is no adhesion, bacteria and fungi
cannot grow and form colonies and, if there is no
colonisation, there is no infection and no disease
(15,16).
As the mucosal surfaces of the genitourinary,
respiratory and gastrointestinal tracts are the most
common portals of entry for micro-organisms, and
the sites where they make contact with and adhere to
the human body, the pathogenic mechanisms of bac-
terial and fungal adhesion have been widely studied.
It is now generally accepted that bacterial and fun-
gal adhesion of mucosal epithelial cells is a prerequisi-
te and obligatory first step in the pathogenesis of
many bacterial and fungal infections. This is particu-
larly true in the case of female urogenital infections,
such as urinary tract infections, bacterial vaginosis
and vaginitis (17).
Under normal conditions, the microbial flora in
the vagina of healthy women is a natural ecosystem in
which pathogenic and non-pathogenic micro-organi-
sms are balanced. Urinary tract infections, bacterial
vaginosis and yeast vaginitis afflict an estimated
1,000,000,000 people in the world every year (17) as a
result of the disturbed ecological balance of local
microflora and micro-organism colonisation of the
perineum, the vagina and periurethra extending to the
bladder. One common approach to counteracting this
situation is the use of antibiotics or antimycotics
which can still inhibit bacterial or fungal adhesion to
human mucosal cells (15,16) even at subinhibitory
concentrations.
The effect of thymol on bacterial and fungal adhe-
sion to human vaginal epithelial cells (VECs) has
been investigated using the same method.
In a first study of Gram-negative and Gram-posi-
tive bacteria adhesion, thymol MIC values for three
Escherichia coli strains ranged from 125 to 245 µg/ml
(means ±SD = 181±60 µg/ml), and the MIC for
three strains of Staphylococcus aureus was 175 µg/ml.
These MICs are in the same order of magnitude as
the 100 µg/ml (13-15) to 250 µg/ml (18) found by
other authors.
Given the different starting adhesion values of the
different strains, the baseline adhesion values were
normalised to 100 and the results were expressed in
percentages. Figure 1 shows the effects of thymol
sub-MICs on the adhesion of E. coli to human VECs.
The concentration of 1/2 MIC induced the greatest
inhibition, with values gradually returning to baseline
from 1/2 to 1/64 MIC, and the differences were sta-
tistically significant between 1/2 MIC and 1/32 MIC.
Fig. 1 also shows the findings obtained when the
VECs were incubated with different thymol sub-
MICs before being challenged with untreated E. coli.
In this case, bacterial adhesion was not significantly
different from that of the controls, thus indicating
that thymol did not interfere with vaginal cell recep-
tors.
In a third series of experiments, in which E. coli,
vaginal cells and thymol were incubated together
there was a significant inhibition of adhesion at thy-
mol concentrations of between 1/2 MIC and 1/32
MIC (Fig. 1) (19). Figures 2A and 2B are scanning
electron micrographs showing examples of the adhe-
sion of E. coli to human VECs under baseline condi-
tions (without thymol), and when the bacteria and the
cells were incubated with 1/2 MIC of thymol (19).
Inhibition of adhesion was also observed in the
case of S. aureus strains. As expected, the concentra-
tions of 1/2 MIC (Fig. 3) induced the greatest inhibi-
tion, but the degree of inhibition remained statistical-
ly significant down to 1/16. The effect of thymol on
VECs subsequent challenged with untreated S. aureus
were not different from its effect on controls and,
when S. aureus, vaginal cells and thymol were incuba-
ted together, the inhibition of adhesion was signifi-
cant from 1/2 MIC to 1/16 MIC of thymol (Fig. 3)
(19). Figures 4A and 4B are scanning electron micro-
graphs showing examples of the adhesion of S. aureus
to human VECs under baseline conditions (without
Fig. 1 - Comparative plot of the percentages of inhibition of E. coli adhe-




thymol), and when the bacteria and the cells were
incubated with 1/2 MIC of thymol (19).
The same methodology was used to assess
whether thymol interferes with the adhesion of four
strains of Candida albicans to human vaginal epithelial
cells. The thymol MIC values were 125 µg/ml for
three strains, and 150 µg/ml for one (mean value
131.25 ± 12.5 µg/ml). When thymol sub-MICs were
incubated with the VECs and then challenged with
untreated Candida albicans, the adhesion of all the
strains was not significantly different from that of the
controls, thus indicating that thymol did not interfere
with surface vaginal cell receptors (Fig. 5). In a second
set of experiments, the reduction in adhesiveness was
maximal at 1/2 MIC and progressively returned to
mean control values. There was a significant reduction
in the mean number of Candida cells adhering to
VECs at up to 1/8 MIC (Fig. 5). In a final set of
experiments, in which Candida strains, VECs and thy-
mol were incubated together, 1/2 MIC concentra-
tions induced the greatest inhibition, but the degree
of inhibition remained statistically significant down to
1/8 MIC (Fig. 5) (20).
Figures 6A and 6B are scanning electron micro-
graphs showing examples of the adhesion of Candida
spp to human VECs under baseline conditions
(without thymol), and when the fungi and cells were
incubated with 1/2 MIC of thymol (20).
Products containing essential oil of plants and
designed for the treatment of vaginal conditions are
now available in the UK, USA, Australia and Europe
(21, 22, 23).
Monoterpenes are substances derived from isopre-
ne hydrocarbure (2-methyl-1,3-butadiene) and origi-
nated by attaching two or more isoprene molecules
(24). They can be found as components of many
essential oils and include thymol. Interest in isolated
monoterpenes has been growing because of their
pharmacological usefulness, and this is particularly
true of thymol, which is widely known as antimicro-
bial and antifungal agent (24).
From a biophysical point of view, thymol has
amphipatic and/or hydrophobic behaviour, which
suggests its ability to affect the structure of cell mem-
branes and surface electrostatics, and thus generate
asymmetries in membrane tensions (24). This
assumption has been confirmed by the observation
that terpenes enter between the fatty acyl chains
making up the membrane lipid bilayer (25,26), disrupt
lipid packing, and cause changes to membrane pro-
perties and functions (26,27,2) by increasing membra-
ne fluidity and altering permeability (28, 29). Terpenes
also inhibit respiration in Candida, thus suggesting
adverse effects on mitochondria (28).
As bacterial and fungal cells must keep their struc-
Fig. 2 - A) Scanning electron micrograph (SEM) of human vaginal epithe-
lial cells showing the large number of adherent E. coli in the absence of
thymol.
Fig. 3 - Comparative plot of the percentages of inhibition of S. aureus
adhesion to human vaginal cells at different sub-MICs of thymol 
Fig. 2 - B) Example of the large reduction in the number of adherent E. coli




ture intact and have a proper surface fibrillar layer in
order to adhere (30, 31, 32), any compound that alters
their structure (thymol in this case) is also capable of
modifying their adhesiveness.
Our findings indicate that subinhibitory concen-
trations of thymol can interfere with the mechanisms
of bacterial and fungal adhesion to human VECs (19,
20).
Phenolic compounds such as thymol also have
anti-oxidant activity. This is important because bacte-
rial or fungal infection generally lead to the recruit-
ment of poymorphonuclear neutrophils (PMNs), the
major cell mediators of inflammation. During respira-
tory bursts and the killing of micro-organisms, PMNs
generate reactive oxygen species (ROS) whose release
can induce oxidative stress and tissue injury.
Fig. 4 - A) Scanning electron micrograph (SEM) of human vaginal epithe-
lial cells showing the large number of adherent S.aureus in the absence of
thymol. 
Fig. 4 - B) Example of the large reduction in the number of adherent
S.aureus after incubation with 1/2 MIC of thymol.
Fig. 5 - Comparative plot of the percentages of inhibition of C. albicans
adhesion to human vaginal cells at different sub-MICs of thymol.
Fig. 6 - A) Scanning electron micrograph of human vaginal epithelial cell
showing the large number of adherent C. albicans in the absence of thy-
mol. 
Fig. 6 - B) Example of the large reduction in the number of adherent C.
albicans cells after incubation with 1/2 MIC of thymol.
The therapeutic strategies for decreasing oxidant
damage to cells during inflammation and PMN respi-
ratory bursts therefore include removing specific
cause, increasing intracellular anti-oxidant systems,
and administering anti-oxidant agents. This last
approach is interesting because it can be easily adop-
ted, and so we investigated whether thymol can inter-
fere with the production of O2-. and derived reactive
oxygen species during neutrophil respiratory bursts
using luminol amplified chemiluminescence and the
soluble N-formyl-methionyl-leucyl-phenylalanine sti-
mulant.
Thymol incubated with human neutrophils signi-
ficantly reduced oxidative bursts down to 2.73 µg/ml,
a very low concentration (Fig. 7) (33).
The anti-oxidant activity of thymol has been attri-
buted to its phenolic structure (34, 35, 36, 37), and
the anti-oxidant activity of phenolic compounds is
mainly due to their redox properties, which can play
an important role in adsorbing and neutralising free
radicals or decomposing peroxides (37). Carvacrol,
another molecule with phenolic structure, is found in
various concentrations in the essential oils of the
Thymus species, and also possess anti-oxidant activity
(34, 35, 36, 37). Together with the other findings con-
cerning bacterial and fungal adhesion, the anti-oxi-
dant activity of thymol is useful for the strategy of
protecting against vaginosis or vaginitis using new
compounds other than antibiotics or antimycotics
because the presence in only one molecule of anti-
bacterial, antifungal and anti-oxidant activities may
have synergistic effects.
Fig. 7 - Effect of various concentrations of thymol on LACL of PMN respi-
ratory burst by fMLP stimulation.
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